Propanc Biopharma Inc. (PPCB)
NASDAQ · Healthcare
Propanc Biopharma Inc. Shareholder Equity 2020–2025
Propanc Biopharma Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Propanc Biopharma Inc. shareholder equity as of June 30, 2025: 13.9M, a 467.98% decrease year-over-year.
- Propanc Biopharma Inc. shareholder equity for 2025 were 13.9M, a 467.98% decrease from 2024.
- Propanc Biopharma Inc. shareholder equity for 2024 were -3.8M, a 21.23% increase from 2023.
- Propanc Biopharma Inc. shareholder equity for 2023 were -3.1M, a 3.09% increase from 2022.
- Propanc Biopharma Inc. shareholder equity for 2022 were -3.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Propanc Biopharma Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $14 |
| 2024 | $-4 |
| 2023 | $-3 |
| 2022 | $-3 |
| 2021 | $-3 |
| 2020 | $-4 |
Propanc Biopharma Inc. Shareholder Equity — FAQ
Propanc Biopharma Inc. (PPCB) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PPCB's shareholder equity history?
The chart and table above show Propanc Biopharma Inc.'s shareholder equity by year and by quarter, including the growth rate.